Symbol Name ID |
Slc22a3
solute carrier family 22 (organic cation transporter), member 3 MGI:1333817 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
Slc22a3em1(IMPC)Mbp/Slc22a3em1(IMPC)Mbp C57BL/6N-Slc22a3em1(IMPC)Mbp/MbpMmucd |
abnormal behavior | J:211773 |
abnormal eye morphology | J:211773 | |
anophthalmia | J:211773 | |
decreased anxiety-related response | J:211773 | |
decreased locomotor activity | J:211773 | |
decreased thigmotaxis | J:211773 | |
hyperactivity | J:211773 | |
Slc22a3tm1Dpb/Slc22a3tm1Dpb involves: 129P2/OlaHsd |
abnormal dopamine level | J:180517 |
increased susceptibility to dopaminergic neuron neurotoxicity | J:180517 | |
Slc22a3tm1Dpb/Slc22a3tm1Dpb involves: 129P2/OlaHsd * FVB/N |
normal behavior/neurological phenotype | J:69978 |
normal cardiovascular system phenotype | J:69978 | |
normal growth/size/body region phenotype | J:69978 | |
normal mortality/aging | J:69978 | |
normal nervous system phenotype | J:69978 | |
normal reproductive system phenotype | J:69978 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/05/2024 MGI 6.24 |
|
|